Emergent BioSolutions has entered a strategic financial investment agreement with Swiss Rockets to support infrastructure ...

Christopher Ridley, a spokesperson for Moderna, said the state legislative efforts are largely a product of ...

India's Syngene International on Monday said it has acquired its first biologics facility in the United States from Emergent ...

India's Syngene International on Monday said it has acquired its first biologics facility in the United States from Emergent ...

Emergent BioSolutions (EBS) is strengthening relationships with partners across sectors and continuing its commitment to ensuring widespread ...

Emergent BioSolutions (EBS) and Rocketvax announced entry into an agreement for Emergent’s strategic financial investment into Swiss Rockets, ...

The company has been selling off its assets after an error caused tens of millions of vaccines to get thrown out during the ...

As part of the investment, Emergent would lead U.S. manufacturing and commercialization efforts for four of Rocketvax’s ...

Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has entered into an agreement to sell its Baltimore-Bayview drug substance manufacturing facility to Syngene International, a leading ...

GAITHERSBURG, Md. and BASEL, Switzerland, March 12, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS), a leading public health company that delivers protective and life-saving ...

Emergent BioSolutions is investing in Swiss biotech Rocketvax, inking a deal designed to fuel the preclinical company’s R&D.